Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade A 76.28 1.72% 1.29
EXAS closed up 1.72 percent on Friday, September 21, 2018, on 75 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical EXAS trend table...

Date Alert Name Type % Chg
Sep 21 20 DMA Support Bullish 0.00%
Sep 21 Pocket Pivot Bullish Swing Setup 0.00%
Sep 21 Bollinger Band Squeeze Range Contraction 0.00%
Sep 21 Up 3 Days in a Row Strength 0.00%
Sep 20 20 DMA Support Bullish 1.72%
Sep 20 Bollinger Band Squeeze Range Contraction 1.72%
Sep 20 BB Squeeze Started Range Contraction 1.72%
Sep 19 Bullish Engulfing Bullish 2.89%
Sep 19 Crossed Above 20 DMA Bullish 2.89%
Sep 19 Stochastic Reached Oversold Weakness 2.89%

Older signals for EXAS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 80.35
52 Week Low 37.36
Average Volume 2,351,390
200-Day Moving Average 55.1617
50-Day Moving Average 64.3174
20-Day Moving Average 74.9955
10-Day Moving Average 75.189
Average True Range 2.8328
ADX 50.2
+DI 37.0132
-DI 15.3063
Chandelier Exit (Long, 3 ATRs ) 71.8516
Chandelier Exit (Short, 3 ATRs ) 67.9984
Upper Bollinger Band 78.4054
Lower Bollinger Band 71.5856
Percent B (%b) 0.69
BandWidth 9.093612
MACD Line 3.4431
MACD Signal Line 4.0464
MACD Histogram -0.6033
Fundamentals Value
Market Cap 9.08 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -59.13
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 79.43
Resistance 3 (R3) 79.27 78.07 78.91
Resistance 2 (R2) 78.07 77.26 78.15 78.73
Resistance 1 (R1) 77.17 76.77 77.62 77.33 78.55
Pivot Point 75.97 75.97 76.19 76.05 75.97
Support 1 (S1) 75.07 75.16 75.52 75.23 74.01
Support 2 (S2) 73.87 74.67 73.95 73.83
Support 3 (S3) 72.97 73.87 73.66
Support 4 (S4) 73.13